This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
by Moumi Mondal
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
UNHNegative Net Change HUMPositive Net Change CVSNegative Net Change
medical medical-devices
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
by Zacks Equity Research
PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.
EWPositive Net Change MASINegative Net Change PLSEPositive Net Change NDRANegative Net Change
medical medical-devices
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
by Santanu Roy
MariMed, Xeris Biopharma and Lam Research shine as Zacks' proven stock strategies continue to beat the market despite turmoil.
UNHNegative Net Change DGXNegative Net Change MUPositive Net Change TMOPositive Net Change LRCXPositive Net Change ORCLNegative Net Change IDCCPositive Net Change MTZPositive Net Change MEGPositive Net Change NOBLNegative Net Change XERSPositive Net Change STNEPositive Net Change
business-services communications computers construction medical semiconductor
5 Value Picks to Ride Out US-China Trade Rift & Government Shutdown
by Rimmi Singhi
Amid U.S.-China tensions and the U.S. government shutdown, five high-earnings-yield value stocks stand out for long-term investors.
MUPositive Net Change STNEPositive Net Change DINOPositive Net Change FTREPositive Net Change AAUCPositive Net Change
gold internet medical oil-energy tech-stocks
Zacks.com featured highlights include StoneCo, Universal Health Services, Integer Holdings and Great Lakes Dredge & Dock
by Zacks Equity Research
Zacks highlights STNE, UHS, ITGR, and GLDD as value stocks with strong cash flow and growth potential amid earnings and government shutdown concerns.
UHSPositive Net Change GLDDPositive Net Change ITGRNegative Net Change STNEPositive Net Change
medical
3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR
by Shaun Pruitt
With investors on edge as the world's two largest economies go head-to-head again, seeking out stocks that can offer defensive safety in the portfolio may be necessary
JNJNegative Net Change GILDPositive Net Change KRNegative Net Change
dividend-investing dividends investing medical pharmaceuticals retail
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
by Zacks Equity Research
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
BDXNegative Net Change RMDNegative Net Change MASINegative Net Change SOLVNegative Net Change
medical medical-devices
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
by Urmimala Biswas
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
LHNegative Net Change CRLPositive Net Change TDOCPositive Net Change
hospitals medical medical-devices smart-health
4 Value Stocks to Buy as Markets Eye Earnings and Government Shutdown
by Sumit Singh
As markets brace for the ongoing government shutdown and earnings season, low Price-to-Cash-Flow stocks like STNE, UHS, ITGR & GLDD offer attractive value opportunities.
UHSPositive Net Change GLDDPositive Net Change ITGRNegative Net Change STNEPositive Net Change
computers construction medical tech-stocks
5 Low-Leverage Stocks to Buy as Market Takes a Tumble
by Aparajita Dutta
As markets tumble, low-leverage stocks like RMD, SAFRY, PNR, CASY, and DRS offer safer investment options for steady returns.
RMDNegative Net Change PNRPositive Net Change CASYNegative Net Change SAFRYNegative Net Change DRSNegative Net Change
aerospace medical retail
OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data
by Zacks Equity Research
Ovid Therapeutics jumps 39% in a month after phase I epilepsy study data show superior efficacy of its lead candidate, OV329, hinting at best-in-class potential.
OVIDNegative Net Change ALLOPositive Net Change AKROPositive Net Change CMMBPositive Net Change
biotechnology biotechs medical pharmaceuticals
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
by Zacks Equity Research
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change PACBPositive Net Change
medical medical-devices
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
by Zacks Equity Research
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change GEHCNegative Net Change
medical medical-devices
Best Momentum Stock to Buy for October 10th
by Zacks Equity Research
SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.
SPRONegative Net Change
medical
Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance?
by Ahan Chakraborty
NVO's $4.7B acquisition of Akero Therapeutics adds a late-stage MASH therapy to its obesity-linked pipeline, advancing its expansion goal beyond semaglutide.
NVOPositive Net Change LLYPositive Net Change VKTXPositive Net Change AKROPositive Net Change
biotechnology biotechs medical pharmaceuticals
Grab These 4 Stocks With Solid Net Profit Margin to Maximize Returns
by Anirudha Bhagat
Let's take a look at four stocks, AVO, ELMD, GLDD and CENX, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
ELMDNegative Net Change GLDDPositive Net Change CENXPositive Net Change AVONegative Net Change
agriculture industrial-products medical medical-devices transportation
TEM Expands Partnership With Northwestern Medicine Amid AI Boom
by Sridatri Sarkar
Tempus AI deepens its collaboration with Northwestern Medicine, embedding its AI co-pilot David directly into the health system's EHR to boost clinical efficiency.
BFLYPositive Net Change GEHCNegative Net Change TEMPositive Net Change
medical
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus
by Zacks Equity Research
ABT's Q3 results may show strength in Medical Devices and Nutrition, offsetting softness in Diagnostics.
ABTNegative Net Change EWPositive Net Change INCYNegative Net Change EXASPositive Net Change
earnings medical
Ecolab Brings Direct-to-Chip Cooling Monitoring to Southeast Asia
by Zacks Equity Research
ECL debuts its 3D TRASAR direct-to-chip cooling monitoring in Singapore, boosting efficiency and sustainability in data centers.
ECLNegative Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
by Zacks Equity Research
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
OMIPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs
by Zacks Equity Research
NEOG's Q1 earnings decline 42.9% year over year, while revenues of $209.2 million top the consensus mark.
BSXNegative Net Change NEOGPositive Net Change PODDNegative Net Change PAHCPositive Net Change
earnings medical medical-devices
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
by Zacks Equity Research
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change ZBHNegative Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Ardent Health Stock?
by Zacks Equity Research
Investors need to pay close attention to Ardent Health stock based on the movements in the options market lately.
ARDTPositive Net Change
medical medical-devices
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
by Zacks Equity Research
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
ISRGNegative Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change
medical medical-devices
Hims & Hers Expands Personalized Care Access Via Telehealth Platform
by Debanjana Dey
HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.
GDRXNegative Net Change HIMSPositive Net Change LFMDPositive Net Change
medical medical-devices